DBF4
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
DBF4 zinc finger | MIM:604281 | Ensembl:ENSG00000006634 | HGNC:HGNC:17364 | PA142672016 | 7q21.12 |
Gene Categories:
DRUGGABLE GENOMEGO terms in DBF4
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IEA | GO:0003676 | nucleic acid binding |
MF | IPI | GO:0005515 | protein binding |
MF | TAS | GO:0008047 | enzyme activator activity |
MF | IEA | GO:0008270 | zinc ion binding |
MF | IBA | GO:0019901 | protein kinase binding |
MF | IBA | GO:0043539 | protein serine/threonine kinase activator activity |
CC | IBA | GO:0005634 | nucleus |
CC | IDA | GO:0005634 | nucleus |
CC | TAS | GO:0005654 | nucleoplasm |
CC | IDA | GO:0016604 | nuclear body |
CC | IBA | GO:0031431 | Dbf4-dependent protein kinase complex |
BP | TAS | GO:0000082 | G1/S transition of mitotic cell cycle |
BP | TAS | GO:0006260 | DNA replication |
BP | IEA | GO:0043085 | positive regulation of catalytic activity |
BP | IBA | GO:0045740 | positive regulation of DNA replication |
Gene expression in normal tissue: DBF4
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in DBF4
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP179 | Cell Cycle |
wikipathways | WP466 | DNA Replication |
kegg | hsa04110 | Cell cycle - Homo sapiens (human) |
reactome | R-HSA-1640170 | Cell Cycle |
reactome | R-HSA-176187 | Activation of ATR in response to replication stress |
reactome | R-HSA-453279 | Mitotic G1-G1/S phases |
reactome | R-HSA-68874 | M/G1 Transition |
reactome | R-HSA-68962 | Activation of the pre-replicative complex |
reactome | R-HSA-69002 | DNA Replication Pre-Initiation |
reactome | R-HSA-69206 | G1/S Transition |
reactome | R-HSA-69278 | Cell Cycle, Mitotic |
reactome | R-HSA-69306 | DNA Replication |
reactome | R-HSA-69481 | G2/M Checkpoints |
reactome | R-HSA-69620 | Cell Cycle Checkpoints |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD420 | Leucascandrolide A | 2 |
iGMDRD1008 | SR-II-138A | 2 |
iGMDRD772 | BRD4770 | 4 |
iGMDRD579 | PF750 | 3 |
iGMDRD387 | CHIR-99021 | 1 |
iGMDRD494 | Neopeltolide | 3 |
iGMDRD466 | Chaetocin | 1 |
iGMDRD394 | BX-795 | 2 |
iGMDRD280 | CYTOCHALASIN B | 4 |
iGMDRD297 | Austocystin D | 1 |
iGMDRD380 | Pifithrin-alpha | 5 |
iGMDRD634 | SCHEMBL2608041 | 3 |
iGMDRD474 | Avrainvillamide | 1 |
iGMDRD247 | Blebbistatin | 5 |
iGMDRD802 | 4-methylfasudil | 3 |
iGMDRD782 | DC-45-A2 | 2 |
iGMDRD171 | Pemetrexed | 2 |
iGMDRD52 | Rotenone | 2 |
iGMDRD318 | PAC-1 | 6 |
iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 2 |
iGMDRD100 | Zebularine | 2 |
iGMDRD888 | Compound 44 | 2 |
iGMDRD577 | BIX01294 | 2 |
iGMDRD224 | Necrostatin-1 | 1 |
iGMDRD506 | Fedratinib | 3 |
iGMDRD64 | Parbendazole | 2 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD690 | PRIMA-1MET | 2 |
iGMDRD268 | Cerulenin | 2 |
iGMDRD23 | Gossypol | 2 |
iGMDRD307 | Manumycin A | 2 |
iGMDRD330 | BRD4132 | 2 |
iGMDRD148 | Pifithrin-mu | 2 |
iGMDRD248 | BRD4354 | 1 |
iGMDRD607 | Ubistatin B | 4 |
iGMDRD424 | Tamatinib | 2 |
iGMDRD345 | Compound 10b [PMID: 11504634] | 2 |
iGMDRD532 | Olaparib | 2 |
iGMDRD219 | Bax channel blocker | 7 |
iGMDRD57 | Chloropentafluorobenzene | 2 |
iGMDRD351 | GW843682X | 1 |
iGMDRD945 | ML214 | 4 |
iGMDRD154 | NSC23766 | 2 |
iGMDRD220 | fumonisin B1 | 1 |
iGMDRD158 | NSC141540 | 2 |
iGMDRD6 | AM-580 | 2 |
iGMDRD231 | Importazole | 2 |
iGMDRD267 | Oligomycin A | 2 |
iGMDRD213 | SMR000068650 | 4 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD871 | BRD6368 | 2 |
iGMDRD329 | Merck60 | 5 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in DBF4